Company news
Expres2ion Biotech Holding Ab (OMXSTO:EXPRS2) news
Expres2ion Biotech Holding Ab news releases on 6ix. Latest, Sep 14, 2026: ExpreS2ion Biotech : Obtains Commitment for Warrant Program TO 13 and enters…
Press releases & updates
ExpreS2ion Biotech : Obtains Commitment for Warrant Program TO 13 and enters into SEK 50 Million Put Option Agreement with lead investor Alumni Capital
September 14, 2026
ExpreS2ion Announces Financial Results for the Second Quarter and First Half of 2026
August 20, 2026
ExpreS2ion annual report for 2025 published
June 4, 2026
ExpreS2ion Announces Financial Results for the First Quarter of 2026
May 28, 2026
ExpreS2ion resolves on a set-off issue to one guarantor in connection with completed rights issue
May 11, 2026
ExpreS2ion Biotech: Rights issue outcome – SEK31.8m raised
May 5, 2026
ExpreS2ion announces final outcome of its rights issue of units
May 4, 2026
ExpreS2ion Biotech advances breast cancer project with rights issue of SEK 53 million
April 20, 2026
ExpreS2ion featured in BioStock investor presentation as subscription period opens in SEK 53 million rights issue
April 16, 2026
ExpreS2ion publishes prospectus in connection with SEK 53 million rights issue to complete Phase I and support partnering activities
April 14, 2026
The Board of Directors of ExpreS2ion has resolved on a rights issue of units of approximately SEK 53 million, primarily to advance its lead cancer program, and publishes terms for the rights issue
April 7, 2026
ExpreS2ion Announces Financial Results for the Full-Year and Fourth Quarter of 2025
February 19, 2026